Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Liquid Molecular Testing Panel in the Community Setting ("DINOSAur II")

Inclusion Criteria: * Patients who have given informed consent in accordance with the methods and procedures of this study * Diagnosis of cancer (stage 3 and stage 4; solid tumors only) requiring medical care * Patients who have not received treatment related to his/her cancer * Patients who are willing to sign a release of medical records to the research team * Male and female patients ≥18 years of age * Patients under oncology care * Sufficient clinical status for collection of blood sample within usual care Exclusion Criteria: * Patients considered minors in the jurisdiction where the protocol is conducted * Patients who are prisoners and pregnant women * Patients who cannot provide consent and did not sign a power of attorney